Cargando…

Vasculitic central retinal vein occlusion: The presenting sign of seronegative rheumatoid arthritis

PURPOSE: To report the case of a patient who presented with a vasculitic central retinal vein occlusion (CRVO), which was the result of an undiagnosed systemic inflammatory condition, seronegative rheumatoid arthritis (RA). OBSERVATIONS: The patient presented with reduced vision in the left eye and...

Descripción completa

Detalles Bibliográficos
Autores principales: Trese, Matthew G.J., Yonekawa, Yoshihiro, Thomas, Benjamin J., Randhawa, Sandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757365/
https://www.ncbi.nlm.nih.gov/pubmed/29503893
http://dx.doi.org/10.1016/j.ajoc.2016.04.007
_version_ 1783290846319214592
author Trese, Matthew G.J.
Yonekawa, Yoshihiro
Thomas, Benjamin J.
Randhawa, Sandeep
author_facet Trese, Matthew G.J.
Yonekawa, Yoshihiro
Thomas, Benjamin J.
Randhawa, Sandeep
author_sort Trese, Matthew G.J.
collection PubMed
description PURPOSE: To report the case of a patient who presented with a vasculitic central retinal vein occlusion (CRVO), which was the result of an undiagnosed systemic inflammatory condition, seronegative rheumatoid arthritis (RA). OBSERVATIONS: The patient presented with reduced vision in the left eye and polyarthralgia. Fundoscopic examination revealed a central retinal vein occlusion (CRVO) with concurrent evidence of vasculitis. Work-up for polyarthralgia included comprehensive serologic testing for connective tissue disease, including Vectra(®) disease activity (DA) testing. Results of these studies confirmed the diagnosis of seronegative rheumatoid arthritis (RA). Systemic steroid therapy was initiated with subsequent anatomic and visual improvement. CONCLUSIONS AND IMPORTANCE: We hypothesize that the systemic inflammation—a hallmark of RA—led to the development of a vasculitic CRVO and, thus, the retinal manifestations served as the disease marker that prompted thorough work-up of the patient's disease, even in the face of initial seronegativity. This case serves as a reminder that, in the setting of CRVO and polyarthralgia, systemic inflammatory conditions must be considered as the underlying etiology. Further, this case report highlights our evolving understanding of the role that serologic markers play in the diagnosis and monitoring of RA.
format Online
Article
Text
id pubmed-5757365
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-57573652018-03-02 Vasculitic central retinal vein occlusion: The presenting sign of seronegative rheumatoid arthritis Trese, Matthew G.J. Yonekawa, Yoshihiro Thomas, Benjamin J. Randhawa, Sandeep Am J Ophthalmol Case Rep Article PURPOSE: To report the case of a patient who presented with a vasculitic central retinal vein occlusion (CRVO), which was the result of an undiagnosed systemic inflammatory condition, seronegative rheumatoid arthritis (RA). OBSERVATIONS: The patient presented with reduced vision in the left eye and polyarthralgia. Fundoscopic examination revealed a central retinal vein occlusion (CRVO) with concurrent evidence of vasculitis. Work-up for polyarthralgia included comprehensive serologic testing for connective tissue disease, including Vectra(®) disease activity (DA) testing. Results of these studies confirmed the diagnosis of seronegative rheumatoid arthritis (RA). Systemic steroid therapy was initiated with subsequent anatomic and visual improvement. CONCLUSIONS AND IMPORTANCE: We hypothesize that the systemic inflammation—a hallmark of RA—led to the development of a vasculitic CRVO and, thus, the retinal manifestations served as the disease marker that prompted thorough work-up of the patient's disease, even in the face of initial seronegativity. This case serves as a reminder that, in the setting of CRVO and polyarthralgia, systemic inflammatory conditions must be considered as the underlying etiology. Further, this case report highlights our evolving understanding of the role that serologic markers play in the diagnosis and monitoring of RA. Elsevier 2016-04-18 /pmc/articles/PMC5757365/ /pubmed/29503893 http://dx.doi.org/10.1016/j.ajoc.2016.04.007 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Trese, Matthew G.J.
Yonekawa, Yoshihiro
Thomas, Benjamin J.
Randhawa, Sandeep
Vasculitic central retinal vein occlusion: The presenting sign of seronegative rheumatoid arthritis
title Vasculitic central retinal vein occlusion: The presenting sign of seronegative rheumatoid arthritis
title_full Vasculitic central retinal vein occlusion: The presenting sign of seronegative rheumatoid arthritis
title_fullStr Vasculitic central retinal vein occlusion: The presenting sign of seronegative rheumatoid arthritis
title_full_unstemmed Vasculitic central retinal vein occlusion: The presenting sign of seronegative rheumatoid arthritis
title_short Vasculitic central retinal vein occlusion: The presenting sign of seronegative rheumatoid arthritis
title_sort vasculitic central retinal vein occlusion: the presenting sign of seronegative rheumatoid arthritis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757365/
https://www.ncbi.nlm.nih.gov/pubmed/29503893
http://dx.doi.org/10.1016/j.ajoc.2016.04.007
work_keys_str_mv AT tresematthewgj vasculiticcentralretinalveinocclusionthepresentingsignofseronegativerheumatoidarthritis
AT yonekawayoshihiro vasculiticcentralretinalveinocclusionthepresentingsignofseronegativerheumatoidarthritis
AT thomasbenjaminj vasculiticcentralretinalveinocclusionthepresentingsignofseronegativerheumatoidarthritis
AT randhawasandeep vasculiticcentralretinalveinocclusionthepresentingsignofseronegativerheumatoidarthritis